-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo From January 11-12, 2023
Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo From January 11-12, 2023
Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo from January 11-12, 2023
LOS ANGELES, CA / ACCESSWIRE / January 9, 2023 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that the Company will attend the 2023 Target Specialty Products National Meeting and Expo ("TSP Expo") from January 11-12, 2023 in Phoenix, Arizona.
The TSP Expo is a national meeting that brings together the top industry suppliers and TSP sales representatives as well as their respective management teams to understand the needs and wants of national pest control operators serviced by Target Specialty Products, a leading value-added service provider to the pest control industry, which allows them to speak to suppliers to evaluate solutions for their respective pest control business customers. The TSP Expo presents a significant sales opportunity to continue converting and adding pest control businesses to the use of Nature-Cide products for the 2023 fiscal year and beyond.
2023 TSP National Meeting + Expo
Date: January 11-12, 2023
Location: Hilton Phoenix Resort at the Peak | Phoenix, AZ
Booth: Number 35
"I am thrilled to attend this incredibly prominent industry event alongside leading national companies such as BASF, FMC and Syngenta - offering ground breaking all-natural solutions to pest control operators, giving them a tool of less environmental impact and exposure to choose from," said Matthew Mills, Chief Executive Officer of Med-X. "The TSP Expo offers an exciting opportunity to continue to place our products in front of potentially thousands of pest control operators continent-wide, providing the chance to become the de-facto standard product line for operators in 2023 and beyond. I look forward to sharing our capabilities at the TSP Expo later this week as we strive to create sustainable, long-term value for our shareholders."
About Med-X, Inc.
Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .
Disclaimer and Forward-Looking Statements
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.
Investor Relations Contact
Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us
SOURCE: Med-X, Inc.
View source version on accesswire.com:
Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo from January 11-12, 2023
Med-X將在2023年1月11日至12日舉行的目標特種產品全國會議和博覽會上展示Natural-Cide產品組合
LOS ANGELES, CA / ACCESSWIRE / January 9, 2023 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that the Company will attend the 2023 Target Specialty Products National Meeting and Expo ("TSP Expo") from January 11-12, 2023 in Phoenix, Arizona.
加利福尼亞州洛杉磯/ACCESSWIRE/2023年1月9日/Med-X公司,面向病蟲害防治、健康和保健市場的全天然綠色場景解決方案的領先創新者今天宣佈,該公司將參加2023年目標專業產品2023年1月11日至12日在亞利桑那州鳳凰城舉行的全國會議和博覽會(TSP EXPO)。
The TSP Expo is a national meeting that brings together the top industry suppliers and TSP sales representatives as well as their respective management teams to understand the needs and wants of national pest control operators serviced by Target Specialty Products, a leading value-added service provider to the pest control industry, which allows them to speak to suppliers to evaluate solutions for their respective pest control business customers. The TSP Expo presents a significant sales opportunity to continue converting and adding pest control businesses to the use of Nature-Cide products for the 2023 fiscal year and beyond.
TSP博覽會是一次全國性的會議,匯集了頂級行業供應商和TSP銷售代表以及他們各自的管理團隊,以瞭解由蟲害防治行業領先的增值服務提供商Target Specialty Products提供服務的全國蟲害防治運營商的需求和需求,這使他們能夠與供應商交談,評估他們各自蟲害防治業務客戶的解決方案。TSP博覽會提供了一個重要的銷售機會,在2023財年及以後繼續轉換和增加蟲害控制業務,以使用Natural-Cide產品。
2023 TSP National Meeting + Expo
Date: January 11-12, 2023
Location: Hilton Phoenix Resort at the Peak | Phoenix, AZ
Booth: Number 35
2023年TSP國家級會議+博覽會
日期:2023年1月11日-12日
地點:山頂希爾頓鳳凰度假村|亞利桑那州鳳凰城
展位:35號
"I am thrilled to attend this incredibly prominent industry event alongside leading national companies such as BASF, FMC and Syngenta - offering ground breaking all-natural solutions to pest control operators, giving them a tool of less environmental impact and exposure to choose from," said Matthew Mills, Chief Executive Officer of Med-X. "The TSP Expo offers an exciting opportunity to continue to place our products in front of potentially thousands of pest control operators continent-wide, providing the chance to become the de-facto standard product line for operators in 2023 and beyond. I look forward to sharing our capabilities at the TSP Expo later this week as we strive to create sustainable, long-term value for our shareholders."
Med-X首席執行官馬修·米爾斯表示:“我很高興能與巴斯夫、FMC和先正達等領先的國家公司一起參加這一令人難以置信的行業盛會--為蟲害防治運營商提供開創性的全天然解決方案,讓他們有一個環境影響更小、風險更小的工具可供選擇。”TSP博覽會提供了一個令人興奮的機會,繼續將我們的產品展示在整個大陸可能數以千計的蟲害防治運營商面前,提供了在2023年及以後成為運營商事實上的標準產品線的機會。我期待著在本週晚些時候的TSP博覽會上分享我們的能力,因為我們努力為我們的股東創造可持續的長期價值。“
About Med-X, Inc.
關於Med-X公司
Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .
Med-X公司是全天然綠色場景解決方案的領先創新者,面向國際蟲害防治,健康狀況和健康度市場。Med-X利用其多樣化的自有品牌系列,提供使用全天然成分的傳統化學和醫藥產品的安全替代品,其全面的市場進入戰略包括在關鍵的國家市場提供集成的電子商務、實體經銷商和現場服務。欲瞭解更多資訊,請訪問。
Disclaimer and Forward-Looking Statements
免責聲明和前瞻性聲明
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.
本新聞稿不構成出售或邀請購買任何證券的要約。任何購買或出售證券的要約、要約或要約都將根據修訂後的1933年證券法(“證券法”)的登記要求進行。本公告是根據《證券法》第135條發佈的。本新聞稿可能包含有關公司的預期業務業績、經營結果、財務狀況和其他方面的前瞻性陳述,用“預期”、“預期”、“預計”和“預測”等語言表達。請注意,此類陳述僅為估計,不能保證前瞻性陳述所陳述或暗示的結果將由公司實際實現。前瞻性陳述可能是基於被證明是錯誤的管理假設。本公司及其業務受到重大風險和非其控制的潛在事件的影響,這些風險和潛在事件將導致預期結果與實際結果之間存在重大差異,包括本公司發生運營虧損和發生意外的重大不利事件。
Investor Relations Contact
投資者關係聯繫人
Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us
盧卡斯·齊默爾曼
董事
MZ集團-MZ北美
262-357-2918
郵箱:mxrx@mzgroup.us
SOURCE: Med-X, Inc.
資料來源:Med-X公司
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧